Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that the Nomination and Remuneration Committee of the Company, in its meeting held today 21st January, 2025 has approved the allotment of 65,700 equity shares of face value of Rs. 2/- each to the Indoco Employees Welfare Trust (‘ESOP Trust’) under Indoco Remedies Limited Employee Stock Option Plan – 2022 (‘Plan’). The shares allotted to the ESOP Trust shall be allocated/ transferred to the Eligible Employees upon Exercise of Options and RSUs. Consequent to this allotment, the paid-up capital of the Company stands increased from Rs. 18,43,64,410 (consisting of 9,21,82,205 equity shares of face value of Rs. 2 each) to Rs. 18,44,95,810 (consisting of 9,22,47,905 equity shares of face value of Rs. 2 each). The Nomination and Remuneration Meeting commenced today at 09:30 a.m. and concluded at 10:10 am. Details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1709.40 |
Dr. Reddys Lab | 1109.75 |
Cipla | 1415.55 |
Lupin | 1971.10 |
Zydus Lifesciences | 866.65 |
View more.. |